44 related articles for article (PubMed ID: 30306879)
1. In silico Molecular Modelling of Selected Natural Ligands and their Binding Features with Estrogen Receptor Alpha.
Maruthanila VL; Elancheran R; Roy NK; Bhattacharya A; Kunnumakkara AB; Kabilan S; Kotoky J
Curr Comput Aided Drug Des; 2019; 15(1):89-96. PubMed ID: 30306879
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, and
Choudhari RC; Kaur K; Das A; Jaitak V
Curr Comput Aided Drug Des; 2024; 20(5):640-652. PubMed ID: 37888813
[TBL] [Abstract][Full Text] [Related]
3. Computational prediction for designing novel ketonic derivatives as potential inhibitors for breast cancer: A trade-off between drug likeness and inhibition potency.
Muhammad S; Zahir N; Bibi S; Alshahrani MY; Shafiq-urRehman ; Chaudhry AR; Sarwar F; Tousif MI
Comput Biol Chem; 2024 Apr; 109():108020. PubMed ID: 38286082
[TBL] [Abstract][Full Text] [Related]
4. Computational Screening of Some Phytochemicals to Identify Best Modulators for Ligand Binding Domain of Estrogen Receptor Alpha.
Alagarsamy V; Sundar PS; Solomon VR; Murugesan S; Muzaffar-Ur-Rehman M; Kulkarni VS; Sulthana MT; Narendhar B; Sabarees G
Curr Pharm Des; 2024 May; ():. PubMed ID: 38698754
[TBL] [Abstract][Full Text] [Related]
5. Repurposing Phytochemicals against Breast Cancer (MCF-7) using Classical Structure-Based Drug Design.
Aldoghachi FEH; Oraibi A; Hamid Mohsen N; Hassan SS
Curr Drug Discov Technol; 2024 Mar; ():. PubMed ID: 38551041
[TBL] [Abstract][Full Text] [Related]
6. Investigating the potent TOPO IIα inhibitors in breast cancer through the study of computational drug discovery research approaches.
Paul P; Iftehimul M; Dey D; Mia MAR; Al-Khafaji K; Pal B; Biswas P; Mandal M; Hasan MN
Mol Divers; 2024 May; ():. PubMed ID: 38773015
[TBL] [Abstract][Full Text] [Related]
7. QSAR, molecular docking, design, and pharmacokinetic analysis of 2-(4-fluorophenyl) imidazol-5-ones as anti-breast cancer drug compounds against MCF-7 cell line.
Lawal HA; Uzairu A; Uba S
J Bioenerg Biomembr; 2020 Dec; 52(6):475-494. PubMed ID: 33247393
[TBL] [Abstract][Full Text] [Related]
8. Unveiling the ESR1 Conformational Stability and Screening Potent Inhibitors for Breast Cancer Treatment.
Sharma K; Panwar U; Madhavi M; Joshi I; Chopra I; Soni L; Khan A; Bhrdwaj A; Parihar AS; Mohan VP; Prajapati L; Sharma R; Agrawal S; Hussain T; Nayarisseri A; Singh SK
Med Chem; 2024; 20(3):352-368. PubMed ID: 37929724
[TBL] [Abstract][Full Text] [Related]
9. Evaluating flavonoids as potential aromatase inhibitors for breast cancer treatment: In vitro studies and in silico predictions.
Seo JI; Yu JS; Zhang Y; Yoo HH
Chem Biol Interact; 2024 Apr; 392():110927. PubMed ID: 38403145
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy.
Yousuf M; Khan P; Shamsi A; Shahbaaz M; Hasan GM; Haque QMR; Christoffels A; Islam A; Hassan MI
ACS Omega; 2020 Oct; 5(42):27480-27491. PubMed ID: 33134711
[TBL] [Abstract][Full Text] [Related]
11. Identification of potent inhibitors of kynurenine-3-monooxygenase from natural products:
Rebai R; Carmena-Bargueño M; Toumi ME; Derardja I; Jasmin L; Pérez-Sánchez H; Boudah A
Heliyon; 2024 May; 10(9):e30287. PubMed ID: 38726174
[TBL] [Abstract][Full Text] [Related]
12. Novel aromatase inhibitors selection using induced fit docking and extra precision methods: Potential clinical use in ER-alpha-positive breast cancer.
Kumavath R; Azad M; Devarapalli P; Tiwari S; Kar S; Barh D; Azevedo V; Kumar AP
Bioinformation; 2016; 12(6):324-331. PubMed ID: 28293075
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Alkyl Triphenylphosphonium Pinostrobin Derivatives as Potent Anti-Breast Cancer Agents.
Tran TH; Le TH; Nguyen TT; Vong LB; Nguyen TMT; Nguyen NT; Dang PH
Chem Biodivers; 2024 May; ():e202400864. PubMed ID: 38699953
[TBL] [Abstract][Full Text] [Related]
14. Screening of natural product libraries in MCF7 cell line reveals the pro-apoptotic properties of β tetralone.
Shaikh N; Sivaram A; Vyas R
J Biomol Struct Dyn; 2024; 42(2):876-884. PubMed ID: 37014028
[TBL] [Abstract][Full Text] [Related]
15. Unusual Nitrogenous Phenalenone Derivatives from the Marine-Derived Fungus Coniothyrium cereale.
Elsebai MF; Ghabbour HA; Mehiri M
Molecules; 2016 Feb; 21(2):178. PubMed ID: 26840293
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of unsymmetrical disulfanes bearing 1,2,4-triazine scaffold and their in vitro screening towards anti-breast cancer activity.
Branowska D; Ławecka J; Sobiczewski M; Karczmarzyk Z; Wysocki W; Wolińska E; Olender E; Mirosław B; Perzyna A; Bielawska A; Bielawski K
Monatsh Chem; 2018; 149(8):1409-1420. PubMed ID: 30100632
[TBL] [Abstract][Full Text] [Related]
17. Development of new steroid-based hydrazide and (thio)semicarbazone compounds with anticancer properties.
Janković ÐD; Šestić TL; Bekić SS; Savić MP; Ćelić AS; Scholda J; Kopp F; Marinović MA; Petri ET; Ajduković JJ
J Steroid Biochem Mol Biol; 2024 May; 242():106545. PubMed ID: 38762058
[TBL] [Abstract][Full Text] [Related]
18. Molecular designing and in silico evaluation of darunavir derivatives as anticancer agents.
Mahto MK; Yellapu NK; Kilaru RB; Chamarthi NR; Bhaskar M
Bioinformation; 2014; 10(4):221-6. PubMed ID: 24966524
[TBL] [Abstract][Full Text] [Related]
19. Potential JAK2 Inhibitors from Selected Natural Compounds: A Promising Approach for Complementary Therapy in Cancer Patients.
Vaziri-Amjad S; Rahgosha R; Taherkhani A
Evid Based Complement Alternat Med; 2024; 2024():1114928. PubMed ID: 38706884
[TBL] [Abstract][Full Text] [Related]
20. Adamantane-derived scaffolds targeting the sigma-2 receptor; an
Alamri MA; Alamri MA
Saudi Pharm J; 2021 Oct; 29(10):1166-1172. PubMed ID: 34703370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
